BioCardia, Inc.
BCDA
$1.96
-$0.145-6.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.18% | -5.53% | 27.39% | -9.41% | 19.50% |
| Total Depreciation and Amortization | -6.25% | -5.88% | -10.53% | -5.00% | -4.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.74% | 12.55% | -17.87% | 3.56% | -19.48% |
| Change in Net Operating Assets | 51.42% | -1,585.90% | -81.73% | 633.75% | 61.54% |
| Cash from Operations | 1.46% | -99.01% | 14.25% | 17.34% | 23.26% |
| Capital Expenditure | 50.00% | 33.33% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.00% | 33.33% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.46% | 289.29% | 26.13% | 8.92% | 1,363.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.77% | -1,635.48% | 31.11% | 60.35% | -51.33% |
| Cash from Financing | -99.75% | 242.59% | 29.87% | 22.97% | 2,029.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.93% | 643.43% | 406.49% | 78.96% | 70.36% |
